Reuters logo
BRIEF-Aralez sees 2018 net revenues $140 mln to $160 mln‍​
2017年11月9日 / 下午12点47分 / 10 天前

BRIEF-Aralez sees 2018 net revenues $140 mln to $160 mln‍​

Nov 9 (Reuters) - Aralez Pharmaceuticals Inc

* Aralez announces third quarter 2017 financial results and achieves profitability on an adjusted EBITDA basis for the first time in the third quarter

* Aralez Pharmaceuticals Inc - ‍provides updated 2017 full-year guidance and preliminary 2018 full-year outlook​

* Aralez Pharmaceuticals Inc - ‍plans to implement further financial improvements designed to streamline U.S. business​

* Aralez Pharmaceuticals Inc - ‍net loss in Q3 of 2017 was $24.4 million, or $0.37 per diluted share​

* Qtrly total revenues, net $24.3 million versus $13.6 mln‍​

* Aralez Pharmaceuticals Inc - ‍updated 2017 net revenues to be in a range of $95 million to $105 million​

* Aralez Pharmaceuticals Inc - sees 2018 net revenues $140 million to $160 million‍​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below